U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C18H39N
Molecular Weight 269.509
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of STEARAMINE

SMILES

CCCCCCCCCCCCCCCCCCN

InChI

InChIKey=REYJJPSVUYRZGE-UHFFFAOYSA-N
InChI=1S/C18H39N/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19/h2-19H2,1H3

HIDE SMILES / InChI
Stearamine is an aliphatic amine intended for use in cosmetic formulations as antistatic agent. In cosmetics and personal care products, Lauramine and Stearamine have been used in hair preparations. Stearamine is also used as a corrosion-inhibiting boiler-water additive. Stearamine has antimicrobial properties. Stearylamine has been shown to prevent drug (lansoprazole) degradation and maintained drug stable in nanostructured lipid carriers (NLCs). Stearamine is used as positive charge inducing agent in different pharmaceutical formulations. Thus, the presence of stearylamine reduced the permeability coefficient for the cationic species of the drugs by approximately an order of magnitude, but had no effect on the neutral species of the drugs. The efflux curves observed for both verapamil and prochlorperazine could be mathematically modeled by assuming that the primary influence of stearylamine was on the development of a positive surface charge density on the inner monolayer of the liposome. Taken in sum, these results indicate that stearylamine is effective at decreasing the leakage of cationic drugs from liposomes, and may prove to be a valuable component of liposomal drug formulations.

Approval Year

PubMed

PubMed

TitleDatePubMed
Superoxide dismutase entrapped in long-circulating liposomes: formulation design and therapeutic activity in rat adjuvant arthritis.
2002 Aug 19
Preparation of novel double liposomes using the glass-filter method.
2002 Nov 6
Stability and release of topical tranexamic acid liposome formulations.
2002 Nov-Dec
[Study on the characteristics of antisense oligodeoxy-neucleotides-liposomes complex and cellular uptake].
2002 Sep
[Protective and rescue effects of transgenic bFGF/GFP expression mediated by cationic liposome on gentamicin-induced guinea pig cochlear toxicity].
2002 Sep 10
Preparation of porous cobalt and nickel oxides from corresponding alkoxides using a sonochemical technique and its application as a catalyst in the oxidation of hydrocarbons.
2003 Jan
Compositional and 2H NMR studies of bis(benzene)chromium composites of mesoporous vanadium-niobium mixed oxides.
2003 Jan 27
Design and characterization of enzymosomes with surface-exposed superoxide dismutase.
2003 Jan 31
Combination of modeling and experiment in structure analysis of intercalated layer silicates.
2003 Jun
Generation of the streaming potential by liposomes in cylindrical capillary. Experimental data.
2003 Mar
Preparation and purification of cationic solid lipid nanospheres--effects on particle size, physical stability and cell toxicity.
2003 Mar 18
Removal characteristics of anionic metals by micellar-enhanced ultrafiltration.
2003 May 30
Stability of desmopressin loaded in liposomes.
2003 Nov
Candida bombicola cells immobilized on patterned lipid films as enzyme sources for the transformation of arachidonic acid to 20-HETE.
2003 Nov-Dec
Two-dimensional crystallization of a small heat shock protein HSP16.3 on lipid layer.
2003 Oct 17
Surface film pressure of actin: interactions with lipids in mixed monolayers.
2003 Sep 5
Relaxation behaviors of monolayers of octadecylamine and stearic acid at the air/water interface.
2004 Apr 13
Effect of salt on the hybridization of DNA by sequential immobilization of oligonucleotides at the air-water interface in the presence of ODA/DOTAP monolayers.
2004 Aug 1
Synthesis of aqueous Au core-Ag shell nanoparticles using tyrosine as a pH-dependent reducing agent and assembling phase-transferred silver nanoparticles at the air-water interface.
2004 Aug 31
Liposomal amikacin dry powder inhaler: effect of fines on in vitro performance.
2004 Aug 9
Development of a topical niosomal preparation of acetazolamide: preparation and evaluation.
2004 Dec
Interactions of lipid monolayers with the natural biopolymer hyaluronic acid.
2004 Dec 15
Preparation of microcapsules containing two-phase core materials.
2004 Dec 7
Cationic stearylamine-containing biodegradable microparticles for DNA delivery.
2004 Feb
Stability and transdermal absorption of topical amphotericin B liposome formulations.
2004 Feb 11
Tunneling characteristics of octadecyl derivatives on tin and indium electrodes.
2004 Feb 3
Molecular transfer and transport in noncovalent microcontact printing.
2004 Feb 3
A low-temperature, soft chemistry method for the synthesis of zirconia nanoparticles in thermally evaporated fatty amine thin films.
2004 Jan 1
Synthesis and evaluation of a hematoporphyrin derivative in a folate receptor-targeted solid-lipid nanoparticle formulation.
2004 Jan-Feb
Invertase-lipid biocomposite films: preparation, characterization, and enzymatic activity.
2004 Jan-Feb
Influence of ammonium nitrate in phase transitions of Langmuir and Langmuir-Blodgett films at air/solution and solid/solution interfaces.
2004 Jul 1
Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
2004 Jul 16
Development of liposomal amphotericin B dry powder inhaler formulation.
2004 Jul-Aug
Formulation and evaluation of oil-in-water emulsions of piperine in visceral leishmaniasis.
2004 Mar
Mineralization mechanism of calcium phosphates under three kinds of Langmuir monolayers.
2004 Mar 16
Sphingolipids as bioactive regulators of thrombin generation.
2004 Mar 26
Lipid nano/submicron emulsions as vehicles for topical flurbiprofen delivery.
2004 Mar-Apr
Kinetic studies of cholesterol oxidation as inhibited by stearylamine during heating.
2004 Nov 17
Determination of aliphatic amines in mineral flotation liquors and reagents by high-performance liquid chromatography after derivatization with 4-chloro-7-nitrobenzofurazan.
2004 Nov 5
A novel preparation of solid lipid nanoparticles with cyclosporin A for prolonged drug release.
2004 Sep
On the mechanism of the hofmeister effect.
2004 Sep 1
Development of simple thiol-reactive liposome formulations, one-step analysis and physicochemical characterization.
2005 Apr
Effect of the intercalation conditions of a montmorillonite with octadecylamine.
2005 Apr 1
Evidence for the role of organic layers in photoconductivity of organic/inorganic hybrid nanosheets as prepared by Langmuir-Blodgett methods.
2005 Apr 21
Structural properties and Raman spectroscopy of lipid Langmuir monolayers at the air-water interface.
2005 Apr 25
Electronic properties of single-walled carbon nanotube networks.
2005 Apr 27
High-throughput mass spectrometer using atmospheric pressure ionization and a cylindrical ion trap array.
2005 Jan 15
Physicochemical characterization and gene transfection efficiency of lipid emulsions with various co-emulsifiers.
2005 Jan 31
Swelling behavior of organoclays in styrene and exfoliation in nanocomposites.
2005 Mar 15
Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B.
2005 Oct 15
Patents

Sample Use Guides

In a subchronic feeding study in rats, 3,000 ppm of Stearamine in the diet caused weight loss and increased mortality, with an accumulation of his- tiocytes in the mucosa of the small intestine and mesenteric lymph nodes. A diet of 500 ppm did not produce these effects. Dogs fed Stearamine at 15 mg/kg/day showed the same histiocyte accumulation. In a 2-year chronic feed- ing study in rats, Stearamine at concentrations up to 500 ppm (maximum tested) showed no significant increase in the incidence of tumors.
Route of Administration: Oral
Name Type Language
STEARAMINE
INCI  
INCI  
Official Name English
STEARAMINE [INCI]
Common Name English
ARMEEN 18
Brand Name English
STEARYL AMINE
Systematic Name English
OCTADECYLAMINE [HSDB]
Common Name English
NSC-9857
Code English
1-OCTADECANAMINE
Systematic Name English
OCTADECYLAMINE
HSDB  
Systematic Name English
STEARYLAMINE
Systematic Name English
ARMEEN 18D
Brand Name English
Classification Tree Code System Code
CFR 21 CFR 200.11
Created by admin on Fri Dec 15 15:04:50 GMT 2023 , Edited by admin on Fri Dec 15 15:04:50 GMT 2023
Code System Code Type Description
ECHA (EC/EINECS)
204-695-3
Created by admin on Fri Dec 15 15:04:50 GMT 2023 , Edited by admin on Fri Dec 15 15:04:50 GMT 2023
PRIMARY
EPA CompTox
DTXSID1025801
Created by admin on Fri Dec 15 15:04:50 GMT 2023 , Edited by admin on Fri Dec 15 15:04:50 GMT 2023
PRIMARY
RXCUI
1313977
Created by admin on Fri Dec 15 15:04:50 GMT 2023 , Edited by admin on Fri Dec 15 15:04:50 GMT 2023
PRIMARY RxNorm
MESH
C009317
Created by admin on Fri Dec 15 15:04:50 GMT 2023 , Edited by admin on Fri Dec 15 15:04:50 GMT 2023
PRIMARY
EVMPD
SUB126410
Created by admin on Fri Dec 15 15:04:50 GMT 2023 , Edited by admin on Fri Dec 15 15:04:50 GMT 2023
PRIMARY
SMS_ID
100000151965
Created by admin on Fri Dec 15 15:04:50 GMT 2023 , Edited by admin on Fri Dec 15 15:04:50 GMT 2023
PRIMARY
CAS
124-30-1
Created by admin on Fri Dec 15 15:04:50 GMT 2023 , Edited by admin on Fri Dec 15 15:04:50 GMT 2023
PRIMARY
PUBCHEM
15793
Created by admin on Fri Dec 15 15:04:50 GMT 2023 , Edited by admin on Fri Dec 15 15:04:50 GMT 2023
PRIMARY
FDA UNII
FFV58UNY7O
Created by admin on Fri Dec 15 15:04:50 GMT 2023 , Edited by admin on Fri Dec 15 15:04:50 GMT 2023
PRIMARY
NSC
9857
Created by admin on Fri Dec 15 15:04:50 GMT 2023 , Edited by admin on Fri Dec 15 15:04:50 GMT 2023
PRIMARY
CHEBI
63866
Created by admin on Fri Dec 15 15:04:50 GMT 2023 , Edited by admin on Fri Dec 15 15:04:50 GMT 2023
PRIMARY
HSDB
1194
Created by admin on Fri Dec 15 15:04:50 GMT 2023 , Edited by admin on Fri Dec 15 15:04:50 GMT 2023
PRIMARY